- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Wockhardt raises Rs 480 crores via QIP
With the closure of its recent Qualified Institutional Placement (QIP), Wockhardt has now raised Rs 480 crores. The share allotment committee allotted a total of 92,85,163 equity shares to eligible Qualified Institutional Buyers (QIBs), including prominent investors like Madhusudan Kela's Cohesion MK Best Ideas and Prashant Jain's 3P India Equity, among others.
According to the BSE filing, 3P India Equity, managed by Prashant Jain, was allotted 14,89,360 shares, which represents 16.04 percent of the QIP size. Meanwhile, Cohesion MK Best Ideas, led by Madhusudan Kela, received 5,80,270 shares, equivalent to 6.25 percent of Wockhardt's QIP size.
ICICI Prudential secured 19,34,235 shares, equivalent to 20.83 percent of total Wockhardt's QIP size. These shares were allotted to various ICICI Prudential schemes by Wockhardt share allotment committee.
Mirae Asset Fund received 8,70,406 shares, amounting to 9.37 percent of Wockhardt's QIP size. Invesco India Smallcap Fund obtained 5,80,270 shares, constituting 6.25 percent of the QIP shares offered by the pharmaceutical company.
Other notable institutions such as Tata Indian opportunities fund, Gagandeep Credit Capital, and Subhkam Ventures also received shares through the QIP share allotment process.
List of allottees who have been allotted more than 5 per cent (5%) of the equity share issued in the qualified institutions placement
Sr. No. | Name of the Allottees | Shares allotted | % shares allotted to total Issue Size |
1(a) | ICICI PRUDENTIAL ELSS TAX SAVER FUND | 6,10,700 | 6.58% |
1(b) | ICICI PRUDENTIAL EQUITY & DEBT FUND | 7,43,264 | 8.00% |
1(c ) | ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICS (P.H.D) FUND | 5,80,271 | 6.25% |
Sub-total | 19,34,235 | 20.83% | |
2 | TATA INDIAN OPPORTUNITIES FUND | 13,53,965 | 14.58% |
3 | 3P INDIA EQUITY FUND 1 | 14,89,360 | 16.04% |
4(a) | MIRAE ASSET HEALTHCARE FUND MIRAHCFD | 4,83,556 | 5.21% |
4(b) | MIRAE ASSET FLEXI CAP FUND | 1,54,740 | 1.67% |
4(c ) | MIRAE ASSET MULTICAP FUND | 2,32,110 | 2.50% |
Sub-total | 8,70,406 | 9.37% | |
5 | COHESION MK BEST IDEAS SUB-TRUST | 5,80,270 | 6.25% |
6 | INEVSCO INDIA SMALLCAP FUND . | 5,80,270 | 6.25% |
7 | GAGANDEEP CREDIT CAPITAL PVT LTD | 5,07,000 | 5.46% |
8 | SUBHKAM VENTURES I PVT LTD | 5,00,000 | 5.38% |
Wockhardt Ltd offered a total of 92,85,163 shares to Qualified Institutional Investors at Rs 517 each, aiming to raise approximately Rs 480 crore through the QIP.
The company officially closed this Rs 480 crore QIP on Tuesday, announcing the allotment of shares to eligible QIBs.
Read also: Wockhardt gets CDSCO Panel nod to study Biphasic insulin aspart
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751